Cabot Co. (NYSE:CBT) Shares Bought by Pathway Financial Advisers LLC

Pathway Financial Advisers LLC lifted its stake in shares of Cabot Co. (NYSE:CBT - Free Report) by 11,108.7% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 7,734 shares of the specialty chemicals company's stock after purchasing an additional 7,665 shares during the period. Pathway Financial Advisers LLC's holdings in Cabot were worth $864,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Wolff Wiese Magana LLC acquired a new position in Cabot in the 3rd quarter valued at about $25,000. CWM LLC lifted its holdings in Cabot by 60.6% in the second quarter. CWM LLC now owns 416 shares of the specialty chemicals company's stock valued at $38,000 after acquiring an additional 157 shares during the last quarter. UMB Bank n.a. grew its position in Cabot by 53.9% in the third quarter. UMB Bank n.a. now owns 371 shares of the specialty chemicals company's stock worth $41,000 after acquiring an additional 130 shares during the period. EverSource Wealth Advisors LLC raised its position in Cabot by 33.4% in the second quarter. EverSource Wealth Advisors LLC now owns 475 shares of the specialty chemicals company's stock valued at $48,000 after purchasing an additional 119 shares during the period. Finally, 1620 Investment Advisors Inc. acquired a new position in shares of Cabot in the 2nd quarter valued at $49,000. 93.18% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Cabot

In other news, CFO Erica Mclaughlin sold 23,274 shares of the company's stock in a transaction on Wednesday, August 7th. The shares were sold at an average price of $99.79, for a total value of $2,322,512.46. Following the completion of the transaction, the chief financial officer now owns 59,814 shares in the company, valued at approximately $5,968,839.06. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. In other news, EVP Jeff Ji Zhu sold 1,201 shares of Cabot stock in a transaction on Monday, August 26th. The shares were sold at an average price of $106.19, for a total value of $127,534.19. Following the transaction, the executive vice president now directly owns 96,000 shares of the company's stock, valued at $10,194,240. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Erica Mclaughlin sold 23,274 shares of the company's stock in a transaction on Wednesday, August 7th. The shares were sold at an average price of $99.79, for a total transaction of $2,322,512.46. Following the completion of the sale, the chief financial officer now owns 59,814 shares of the company's stock, valued at approximately $5,968,839.06. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 71,939 shares of company stock valued at $7,308,812. Corporate insiders own 3.07% of the company's stock.

Cabot Stock Down 2.2 %

NYSE:CBT traded down $2.41 during mid-day trading on Thursday, hitting $107.83. The stock had a trading volume of 477,101 shares, compared to its average volume of 332,914. The company has a current ratio of 2.22, a quick ratio of 1.45 and a debt-to-equity ratio of 0.72. Cabot Co. has a twelve month low of $65.38 and a twelve month high of $117.14. The company has a market capitalization of $5.91 billion, a PE ratio of 13.10, a PEG ratio of 0.93 and a beta of 1.19. The stock has a 50-day simple moving average of $107.97 and a two-hundred day simple moving average of $100.59.

Cabot (NYSE:CBT - Get Free Report) last released its quarterly earnings data on Monday, August 5th. The specialty chemicals company reported $1.92 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.72 by $0.20. Cabot had a net margin of 12.05% and a return on equity of 26.99%. The business had revenue of $1.02 billion during the quarter, compared to analysts' expectations of $1 billion. During the same period in the previous year, the company earned $1.42 EPS. The company's revenue for the quarter was up 5.0% on a year-over-year basis. On average, equities research analysts anticipate that Cabot Co. will post 7.07 EPS for the current year.

Analyst Ratings Changes

Several analysts recently issued reports on CBT shares. JPMorgan Chase & Co. boosted their price objective on shares of Cabot from $95.00 to $105.00 and gave the company a "neutral" rating in a report on Wednesday, August 7th. UBS Group dropped their price target on shares of Cabot from $103.00 to $98.00 and set a "neutral" rating for the company in a research note on Tuesday, August 6th. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, Cabot presently has an average rating of "Hold" and an average target price of $101.75.

Cabot Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.